Cordlife Group (SGX:P8A), a cord blood banking company, has been directed by the Ministry of Health (MOH) to comply with new operational restrictions starting Sept. 15, according to a Friday filing on the Singapore Exchange.
Under the Third Notice issued by the MOH, the company must limit its cord blood collection, testing, processing, and storage to 30 units per month until Jan. 13, 2025.
The company has confirmed it will adhere to these restrictions, which will impact its operations and are expected to negatively affect its financial performance for the fiscal year ending Dec. 31, 2024.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。